Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

NCT00391274

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China
View Trial Details
Completed

Performance Status During Treatment With Pemetrexed in Patients With NSCLC

NCT00540241

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Homburg, Germany
View Trial Details
Completed

Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer

NCT00687817

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Apollo Hospital Bannerghatta Rd, Banglore, India
  • Kidwai Hospital Munigowda Road, Banglore, India
  • M S Ramaiah Hospital New BEL Rd, Banglore, India
  • Bangalore Institute of Oncology Speciality Centre Sampangi Ram Nagar, Banglore, India
View Trial Details
Completed

Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

NCT01081496

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Santiago de Compostela, A Coruna, Spain
  • Research Site Albacete, Spain
  • Research Site Alicante, Spain
  • Research Site Elche, Alicante, Spain
View all 24 locations
View Trial Details
Completed

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

NCT00372775

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +14 more
Locations
  • Pfizer Investigational Site Norwalk, Connecticut, United States
  • Pfizer Investigational Site Cocoa Beach, Florida, United States
  • Pfizer Investigational Site Merritt Island, Florida, United States
  • Pfizer Investigational Site Titusville, Florida, United States
View all 27 locations
View Trial Details
Completed

Iressa Case Control Study in Japan

NCT00252759

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Nagoya, Aichi-ken, Japan
  • Research Site Okazaki, Aichi-ken, Japan
  • Research Site Toyoake, Aichi-ken, Japan
  • Research Site Imba-gun, Chiba, Japan
View all 44 locations
View Trial Details

Related conditions